Satellos Bioscien…
CACADSatellos Bioscience Inc. (TO:MSCL) — Biotechnology: Pharmaceutical Preparations. Biržu skaits, kurās tiek tirgotas uzņēmuma akcijas: 2. Šajā lapā — cena un grafiks, dividendes, lielākie akcionāri un akciju skaita vēsture.
Par Uzņēmumu
- Tīmekļvietne
- satellos.com
- Nozare
- Health Care · Biotechnology: Pharmaceutical Preparations
- Galvenā Mītne
- MARKHAM, Canada
- Izpilddirektors
- Francis Gleeson
- Darbinieki
- 18
- Apgrozībā Esošās Akcijas
- 21.22 milj.
- Brīvā Apgrozība
- 18.02 milj.
- Tirgus Kapitalizācija
- 207.71 milj. CAD
- Iekšējās Personas
- 6.37%
- Institucionālie Investori
- 49.7%
- Nozare (SIC)
- Pharmaceutical Preparations
- P/E
- zaudējumi
- FCF
- −23.6 milj. USD
- Parāds
- ?
- Peļņa un FCF — par 12 mēnešiem līdz 31.12.2025 (uzņēmuma jaunākais ziņojums).
Apraksts
Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. The company uses its proprietary discovery platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247, an oral, small molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.
Lielākie Akcionāri
| Turētājs | Daļa | Akcijas | Pārskata Datums |
|---|---|---|---|
| Franklin Resources, Inc. | 4.42% | 938 666 | 2026-06-30 |
| Siren, L.L.C. | 4.2% | 892 074 | 2026-06-30 |
| Vivo Capital, LLC | 3.84% | 813 666 | 2026-06-30 |
| Berger (Franklin Milan)… | ≈3.25% | 688 258 | 2026-07-14 |
| Point72 Asset Management… | 3.22% | 682 700 | 2026-06-30 |
| Sphera Funds Management… | 3.08% | 652 590 | 2026-06-30 |
| Woodline Partners LP | 2.36% | 500 432 | 2026-06-30 |
| Stonepine Capital Manage… | 2.32% | 491 624 | 2026-06-30 |
| Montanova Capital LLC | 2.24% | 475 000 | 2026-06-30 |
| Avidity Partners Managem… | 1.83% | 387 769 | 2026-06-30 |
| Saturn V Capital Managem… | 1.65% | 350 000 | 2026-06-30 |
| Franklin Strategic Serie… | 1.62% | 343 237 | 2026-07-31 |
| Gleeson (Francis Michael… | ≈1.27% | 269 851 | 2026-01-30 |
| Rudnicki (Michael Anthon… | ≈1.22% | 258 159 | 2026-01-30 |
| Bloom (Brian Matthew) (D… | ≈0.32% | 67 233 | 2026-01-30 |
| MacKay (Geoffrey Ross) (… | ≈0.1% | 21 201 | 2026-01-30 |
| Fidelity Concord Street… | 0.06% | 13 021 | 2026-08-31 |
| Williams (Elizabeth) (Se… | ≈0.02% | 3 333 | 2026-01-30 |
| Nawacki (Mark Henry CPA)… | — | — | 2026-06-18 |
Pieslēdzies ar Google